In conclusion, our study emphasizes the pivotal role of the TGF-β1 pathway in understanding early-phase fibrotic abnormalities in survivors of COVID-19-induced ARDS 6-months after ICU discharge. Here, TGFB1 is linked to acute respiratory distress syndrome.